Abstract: A variable length sequential iterable convolutional recurrent network (VS-ICRN) is proposed in this article, aiming at improving the vehicle target recognition ability for the ultrawideband ...
The FDA approved the combination of relacorilant and nab-paclitaxel in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. The FDA has approved relacorilant (Lifyorli) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results